Iran Faces COVID Surge in Southwest, Receives Second Vaccine Batch

A member of the Imam Khomeini Hospital medical personnel receives a dose of Russia’s Sputnik V vaccine against the coronavirus disease (COVID-19), in Tehran, Iran February 9, 2021. Photo: Majid Asgaripour/WANA (West Asia News Agency) via REUTERS

Iran declared 10 southwestern communities as high-risk COVID-19 “red” zones as a consignment of 100,000 doses of the Russian Sputnik V vaccine arrived on Friday, Iranian media reported.

Iran launched a vaccination drive on Tuesday, two weeks after declaring there were no “red” cities left in the hardest-hit country in the Middle East. The inoculation focuses on hospital intensive care personnel as authorities await enough vaccines for the general population.

But Ahvaz, capital of oil-rich Khuzestan province and nine other cities and towns were declared “red” zones after a rise in cases and health authorities ordered non-essential businesses to close, the semi-official news agency ISNA said.

“Following a decrease in the observance of health precautions and the belief that the situation has returned to normal, the number of referrals to hospitals has increased,” Farhad Abolnejadian, head of the medical university in Ahvaz, was quoted by ISNA as saying. “Three hospitals in Ahvaz are at full capacity.”

State television said 100,000 of the 2 million doses of Sputnik V vaccine that Iran had ordered arrived on Friday and Russia may increase the order to 5 million shots and allow Iran to produce the vaccine locally.

Iran plans to vaccinate 1.3 million people by March 20.

Iran also expects to receive more than 4 million doses of AstraZeneca’s shot, despite a ban by its top authority, Supreme Leader Ayatollah Ali Khamenei, on importing US- and British-made vaccines, which he said were unreliable and may be used to spread the infection.

Officials have refrained from referring to Anglo-Swedish AstraZeneca’s British ties.

Iran has recorded 1.5 million cases and 58,809 deaths, with the death toll of 58 on Friday at its lowest for more than eight months, according to health ministry data.

Tehran launched human trials of the first of its three domestic vaccine candidates in December.

Click this link for the original source of this article.
Author: Reuters and Algemeiner Staff


This content is courtesy of, and owned and copyrighted by, https://www.algemeiner.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.

Visit our Discussion Forum at Libertati.com.

Follow us:
WP Twitter Auto Publish Powered By : XYZScripts.com